- Future Students
- Current Students
- Faculty & Staff
Filters: Author is Kolonoski, Peter [Clear All Filters]
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.
Bermudez LE, Inderlied CB, Kolonoski P, Chee CB, Aralar P, Petrofsky M, Parman T, Green CE, Lewin AH, Ellis WY et al.. 2012. Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.. Antimicrobial agents and chemotherapy. 56(8):4202-6.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Motamedi N, Kolonoski P, Chee C, Baimukanova G, Bildfell RJ, Wang G, Phan LT, Lowell YS. 2008. The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection.. The Journal of infectious diseases. 197(11):1506-10.
Bermudez LE, Sangari FJ, Kolonoski P, Petrofsky M, Goodman J. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells.. Infection and immunity. 70(1):140-6.
Bermudez LE, Motamedi N, Chee C, Baimukanova G, Kolonoski P, Inderlied C, Aralar P, Wang G, Phan LT, Young LS. 2007. EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 51(5):1666-70.